Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010

Background. Biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic (ts) DMARDs are important in rheumatoid arthritis (RA) treatment. The risk of hospitalized infection associated with bDMARDs/tsDMARDs in RA patients is unclear. Methods. We retrospectively analyzed the case...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kunihiro Ichinose, Toshimasa Shimizu, Masataka Umeda, Shoichi Fukui, Ayako Nishino, Tomohiro Koga, Shin-ya Kawashiri, Naoki Iwamoto, Mami Tamai, Hideki Nakamura, Shuntaro Sato, Tomoki Origuchi, Atsushi Kawakami
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2018-01-01
coleção:	Journal of Immunology Research
Acesso em linha:	http://dx.doi.org/10.1155/2018/6259010
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!